GRID1
Glutamate receptor ionotropic, delta-1
Also known as: GluD1, GRID1_HUMAN, KIAA1220
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULK0
- Gene
- GRID1
- Ensembl
- ENSG00000182771
- Chromosome
- 10
- Canonical length
- 1009 aa
- Protein class
- Predicted membrane proteins, Transporters
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a subunit of glutamate receptor channels. These channels mediate most of the fast excitatory synaptic transmission in the central nervous system and play key roles in synaptic plasticity.[provided by RefSeq, Jan 2009]
Canonical amino-acid sequenceUniProt
1009 residues, UniProt reviewed canonical sequence.
>Q9ULK0|GRID1
1 MEALTLWLLP WICQCVSVRA DSIIHIGAIF EENAAKDDRV FQLAVSDLSL NDDILQSEKI
61 TYSIKVIEAN NPFQAVQEAC DLMTQGILAL VTSTGCASAN ALQSLTDAMH IPHLFVQRNP
121 GGSPRTACHL NPSPDGEAYT LASRPPVRLN DVMLRLVTEL RWQKFVMFYD SEYDIRGLQS
181 FLDQASRLGL DVSLQKVDKN ISHVFTSLFT TMKTEELNRY RDTLRRAILL LSPQGAHSFI
241 NEAVETNLAS KDSHWVFVNE EISDPEILDL VHSALGRMTV VRQIFPSAKD NQKCTRNNHR
301 ISSLLCDPQE GYLQMLQISN LYLYDSVLML ANAFHRKLED RKWHSMASLN CIRKSTKPWN
361 GGRSMLDTIK KGHITGLTGV MEFREDSSNP YVQFEILGTT YSETFGKDMR KLATWDSEKG
421 LNGSLQERPM GSRLQGLTLK VVTVLEEPFV MVAENILGQP KRYKGFSIDV LDALAKALGF
481 KYEIYQAPDG RYGHQLHNTS WNGMIGELIS KRADLAISAI TITPERESVV DFSKRYMDYS
541 VGILIKKPEE KISIFSLFAP FDFAVWACIA AAIPVVGVLI FVLNRIQAVR AQSAAQPRPS
601 ASATLHSAIW IVYGAFVQQG GESSVNSMAM RIVMGSWWLF TLIVCSSYTA NLAAFLTVSR
661 MDNPIRTFQD LSKQVEMSYG TVRDSAVYEY FRAKGTNPLE QDSTFAELWR TISKNGGADN
721 CVSSPSEGIR KAKKGNYAFL WDVAVVEYAA LTDDDCSVTV IGNSISSKGY GIALQHGSPY
781 RDLFSQRILE LQDTGDLDVL KQKWWPHMGR CDLTSHASAQ ADGKSLKLHS FAGVFCILAI
841 GLLLACLVAA LELWWNSNRC HQETPKEDKE VNLEQVHRRM NSLMDEDIAH KQISPASIEL
901 SALEMGGLAP TQTLEPTREY QNTQLSVSTF LPEQSSHGTS RTLSSGPSSN LPLPLSSSAT
961 MPSMQCKHRS PNGGLFRQSP VKTPIPMSFQ PVPGGVLPEA LDTSHGTSILocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRID1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 5.5 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 5.5 nTPM
- cerebral cortex: 4.7 nTPM
- hippocampal formation: 4.5 nTPM
- amygdala: 4.3 nTPM
- spinal cord: 4.3 nTPM
- hypothalamus: 4.2 nTPM
Single-cell type
- oligodendrocytes: 786 nCPM
- bergmann glia: 598 nCPM
- oligodendrocyte progenitor cells: 588 nCPM
- brain inhibitory neurons: 471 nCPM
- retinal bipolar cells: 401 nCPM
- astrocytes: 321 nCPM
Immune cell
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 17 nTPM
- cerebral cortex: 16 nTPM
- spinal cord: 14 nTPM
- thalamus: 14 nTPM
- basal ganglia: 13 nTPM
- hypothalamus: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GRID1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 160 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- GRID1-associated neurodevelopmental disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.62
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- modulation of chemical synaptic transmission
- negative regulation of synaptic plasticity
- phospholipase C-activating G protein-coupled receptor signaling pathway
- regulation of postsynapse organization
- regulation of postsynaptic membrane neurotransmitter receptor levels
- social behavior
- synaptic signaling via neuropeptide
- synaptic transmission, glutamatergic
Molecular functions
- AMPA glutamate receptor activity
- G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential
- identical protein binding
- transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
- GABA receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ionotropic glutamate receptor, C-terminal
- Ionotropic glutamate receptor, metazoa
- Receptor, ligand binding region
- Ionotropic glutamate receptor
- Ionotropic glutamate receptor, L-glutamate and glycine-binding domain
- Periplasmic binding protein-like I
- Ligand-gated ion channel
- Receptor family ligand binding region
- Ligated ion channel L-glutamate- and glycine-binding site
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRID1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRID1 as an antibody target. Whether an autoantibody or antibody against GRID1 could matter depends on whether native GRID1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRID1 is annotated at the cell surface, where native GRID1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRID1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...